:quality(90)/)
Quick
Multiplex and singleplex CLIA-waived assays with results in 20 minutes or less*, enabling you to act now
Fast results support actionable treatment decisions, reducing over-and-undertreatment of STIs and the need for patient follow up1
*Result times vary by assay
Confident
Gold-standard PCR technology empowering confidence with results you can trust
Lab-quality results inform treatment decisions to aid in antibiotic stewardship
Control
Strategic connectivity enables decentralised testing through centralised control.
Combined with our portfolio of navify digital solutions, the system offers connectivity, interoperability and data privacy in an open and secure ecosystem, which helps drive operational efficiency and improved patient care
Made for the POC
An integrated, easy-to-learn system made for the point of care
CLIA-waived assays enable reliable diagnostic testing in various settings of care
:quality(90)/)
Trusted sexual health testing for everybody, in every setting*
Everyday, more than 1 million people worldwide acquire and STI and cases are on the rise.2 Most STIs are treatable with appropriate, targeted treatment, but appropriate treatment requires and accurate diagnosis.
In addition to the high-throughput regular and routine STI testing provided by labs, clinicians and their patients need more access to STI testing on demand at the point of care. With PCR made for the point of care, the cobas® liat STI panel assays can help enable effective treatment, reduce transmission, and mitigate the growing concerns on antimicrobial resistance.
*Assay performance was not evaluated in individuals younger than 15 years of age
:quality(90)/)
The cobas® liat® system offers a comprehensive and expanding menu of diagnostic tests. Explore how it can revolutionize your point-of-care testing today!
Would you like to know more about the cobas® liat system?
Please submit your information in the following form to be contacted by a Roche representative with more details about the cobas® liat system
Dawkins, M PA, et al. Clinical Integration of a Highly Accurate Polymerase Chain Reaction Point-of-Care Test Can Inform Immediate Treatment Decisions for Chlamydia, Gonorrhea, and Trichomonas. Sexually Transmitted Diseases 49(4):p 262-267, April 2022. | DOI: 10.1097/OLQ.0000000000001586.
World Health Organization, Sexually Transmitted Infections https://www.who.int/health-topics/sexually-transmitted-infections#tab=tab_1. Accessed 1/14/2025.